Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor a antagonists and disease-modifying antirheumatic drugsCURTIS, J. R; MARTIN, C; SAAG, K. G et al.Arthritis care and research. 2007, Vol 57, Num 2, pp 343-346, issn 0893-7524, 4 p.Article

Psoriasis induced by anti-tumor necrosis factor therapy : A class effect?RICHETTE, Pascal; VIGUIER, Manuelle; BACHELEZ, Hervé et al.Journal of rheumatology. 2007, Vol 34, Num 2, pp 438-439, issn 0315-162X, 2 p.Article

Effets paradoxaux des agents anti-TNFαWENDLING, D.La Lettre du rhumatologue. 2007, Num 336, pp 11-12, issn 0761-5027, 2 p., SUPArticle

Immunogénicité des anti-TNFαSARAUX, A.La Lettre du rhumatologue. 2007, Num 336, pp 3-4, issn 0761-5027, 2 p., SUPArticle

A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclooxygenase-2 and tumour necrosis factor α inhibitorsYAZICI, Y; YAZICI, H.Annals of the rheumatic diseases. 2007, Vol 66, Num 1, pp 124-127, issn 0003-4967, 4 p.Article

High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor α inhibitors in rheumatoid arthritisBOBBIO-PALLAVICINI, Francesca; CAPORALI, Roberto; ALPINI, Claudia et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 3, pp 302-307, issn 0003-4967, 6 p.Article

Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapyROUX, C. H; BROCQ, O; BREUIL, V et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 4, pp 695-698, issn 1462-0324, 4 p.Article

Infections et anti-TNF : le bilan après huit ans d'utilisationMARIETTE, Xavier.Revue du rhumatisme (Ed. française). 2007, Vol 74, pp 5-10, issn 1169-8330, 6 p., HS2Article

Que devient la réponse lymphocytaire T sous anti-TNF ? = What happens to T-lymphocyte response in patients treated with TNF antagonists?EMILIE, Dominique.Revue du rhumatisme (Ed. française). 2007, Vol 74, Num 10-11, pp 961-962, issn 1169-8330, 2 p.Conference Paper

Evolution of dermatomyositis during therapy with a tumor necrosis factor α inhibitorHALL, Harald A; ZIMMERMANN, Bernard.Arthritis care and research. 2006, Vol 55, Num 6, pp 982-984, issn 0893-7524, 3 p.Article

Serious infection following anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis : Lessons from interpreting data from observational studiesDIXON, W. G; SYMMONS, D. P. M; LUNT, M et al.Arthritis and rheumatism. 2007, Vol 56, Num 9, pp 2896-2904, issn 0004-3591, 9 p.Article

Le risque de complications cardiovasculaires de la polyarthrite rhumatoïde apparaît diminué sous traitement anti-TNFJACOBSSON, Lennart T. H.Revue du rhumatisme (Ed. française). 2007, Vol 74, pp 2-4, issn 1169-8330, 3 p., HS2Article

L'efficacité des anti-TNF au cours de la polyarthrite rhumatoïde. Objectif rémission en 2007 ?SIBILIA, Jean.Revue du rhumatisme (Ed. française). 2007, Vol 74, pp 11-15, issn 1169-8330, 5 p., HS2Article

Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor a antagonistsCURTIS, Jeffrey R; JUAN XI; PATKAR, Nivedita et al.Arthritis and rheumatism. 2007, Vol 56, Num 12, pp 4226-4227, issn 0004-3591, 2 p.Article

Treatment of Hidradenitis Suppurativa with Tumour Necrosis Factor-α InhibitorsHASLUND, Pia; LEE, Robert A; JEMEC, Gregor B. E et al.Acta dermato-venereologica. 2009, Vol 89, Num 6, pp 595-600, issn 0001-5555, 6 p.Article

The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-α inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in ChinaMANLONG XU; ZHIMING LIN; QU LIN et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 8, pp 1466-1472, issn 1462-0324, 7 p.Article

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor α therapy : Results from the british society for rheumatology biologics registerDIXON, W. G; WATSON, K. D; LUNT, M et al.Arthritis and rheumatism. 2007, Vol 56, Num 9, pp 2905-2912, issn 0004-3591, 8 p.Article

Tolerance and effectiveness of anti-tumor necrosis factor α therapies in elderly patients with rheumatoid arthritis : A population-based cohort studyGENEVAY, Stephane; FINCKH, Axel; CIUREA, Adrian et al.Arthritis care and research. 2007, Vol 57, Num 4, pp 679-685, issn 0893-7524, 7 p.Article

Insulin resistance in patients with rheumatoid arthritis : effect of anti-TNFα therapyROSENVINGE, A; KROGH-MADSEN, R; BASLUND, B et al.Scandinavian journal of rheumatology. 2007, Vol 36, Num 2, pp 91-96, issn 0300-9742, 6 p.Article

Regression to the mean using the disease activity score in eligibility and response criteria for prescribing TNF-α inhibitors in adults with rheumatoid arthritisGREENWOOD, M. C; RATHI, J; HAKIM, A. J et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 7, pp 1165-1167, issn 1462-0324, 3 p.Article

What effects might anti-TNFα treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFα in cardiovascular pathophysiologyDIXON, W. G; SYMMONS, D. P. M.Annals of the rheumatic diseases. 2007, Vol 66, Num 9, pp 1132-1136, issn 0003-4967, 5 p.Article

Traitement anti-TNF en clinique courante. Efficacité sur trois ans chez des patients atteints de polyarthrite rhumatoïde = Anti tumour necrosis factor-alpha therapy in the ordinary clinical setting. Three-year effectiveness in patients with rheumatoid arthritisKVALVIK, Anne Grimstvedt; LEFSAKER, Liv; DYVIK, Siri et al.Revue du rhumatisme (Ed. française). 2007, Vol 74, Num 12, pp 1276-1282, issn 1169-8330, 7 p.Article

Anti-tumor necrosis factor α therapy and the risk of serious bacterial infections in Elderly patients with rheumatoid arthritisSCHNEEWEISS, Sebastian; SETOGUCHI, Soko; WEINBLATT, Michael E et al.Arthritis and rheumatism. 2007, Vol 56, Num 6, pp 1754-1764, issn 0004-3591, 11 p.Article

Assessing the safety of biologic agents in patients with rheumatoid arthritisRUBBERT-ROTH, Andrea.Rheumatology (Oxford. Print). 2012, Vol 51, issn 1462-0324, v38-v47, SUP5Article

QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseasesBARTALESI, F; VICIDOMINI, S; CERINIC, M. M et al.The European respiratory journal. 2009, Vol 33, Num 3, pp 586-593, issn 0903-1936, 8 p.Article